AGP Picks
View all

Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

Press releases published on July 13, 2026

BPX Integrated Toolchain Delivers 33% Process Rationalization Across Five-Continent Enterprise Programs
Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece
Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃,旨在推動神經退行性疾病相關的血漿生物標記研究
Alamar Biosciences 联合多所顶尖研究型大学推出全国性研究计划,推进神经退行性疾病血液生物标志物相关研究
Flyfi Launches Privacy-First Alternative to Mainstream Travel Booking Sites, Powered by Crypto Payments
ProWebChat Introduces AI YOU™ and AI YOU OS™ Expanding static AI Responses into a Personalized Digital Identity Platform
New Axipro study: EU companies hire seven people to build AI for every one hired to govern it
Token Security Named to Prestigious 2026 MES Midmarket 100 List
Songai Media Founder Neil Morecraft Introduces The Awaikened, Sharing The Founder's Journey Through Music
BACK BY POPULAR DEMAND: PALAZZO VERSACE DUBAI BRINGS BACK EXCLUSIVE LIMITED-TIME OFFERS
Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial
Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial
ADI Chain Secures USD 50 Million Strategic Investment to Accelerate Sovereign Digital Infrastructure for Governments and Institutions
Jetex Jakarta: Jetex Announces its Entry into Indonesia's Aviation Market
Checkmarx One for Government Application Security Platform Achieves FedRAMP® Moderate Certification
Integral Metals Announces Planned 2026 Drill Program at the KAP Project, Northwest Territories
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
Apollomics Regains Full Compliance with Nasdaq Listing Requirements

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.